Tailoring access to high cost, genetically targeted drugs.

Hall, Wayne D

Tailoring access to high cost, genetically targeted drugs. [electronic resource] - The Medical journal of Australia Jun 2005 - 607-8 p. digital

Publication Type: Editorial

0025-729X

10.5694/j.1326-5377.2005.tb06844.x doi


Advisory Committees
Australia
Confidentiality
Cost-Benefit Analysis
Decision Making, Organizational
Drug Approval
Drug Costs
Financing, Government
Health Services Accessibility--economics
Humans
Insurance, Pharmaceutical Services--economics
Pharmacogenetics